Last reviewed · How we verify
NCT04419038
Evaluation of Conjunctival Autografting With MMC Application Versus Ologen Implantation of Recurrent Pterygium
NA trial testing conjunctival autografting augmented with topical application of Mitomycin C in Recurrent Pterygium of Eye in 63 participants. Completed in 30 December 2019.
1 December 2019
Quick facts
| Lead sponsor | Menoufia University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 63 |
| Start date | 15 January 2016 |
| Primary completion | 1 December 2019 |
| Estimated completion | 30 December 2019 |
Drugs / interventions tested
- conjunctival autografting augmented with topical application of Mitomycin C
- conjunctival autografting augmented with Ologen implantation
Conditions studied
- Recurrent Pterygium of Eye — all drugs for Recurrent Pterygium of Eye →
Sponsor
Menoufia University
Who can join
Eligibility, any sex, with Recurrent Pterygium of Eye. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ologen implantation with conjunctival autografting shows promising results in surgical management of recurrent pterygium comparable to MMC application with conjunctival autografting with mild non vision threatening postoperative complications.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of Conjunctival Autografting Augmented with Mitomycin C Application <i>versus</i> Ologen Implantation in the Surgical Treatment of Recurrent Pterygium.
Wagdy FM, Farahat HG, Ellakwa AF, Mandour SS. · · 2021 · cited 3× · PMID 33505715 · DOI 10.1155/2021/8820926
Verify or expand the search:
- PubMed search for NCT04419038
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Menoufia University trials
Trials by the same sponsor.
- NCT07522671 — Clinical Performance of 3D-Printed Resin and Zirconia Implant Restorations · NA · recruiting
- NCT07516236 — Dynamic SvO2 in Predicting Fluid Responsiveness in Septic Shock · not yet recruiting
- NCT07485517 — Deep Versus Moderate Neuromuscular Blocking · NA · recruiting
- NCT07506044 — Dexmedetomidine as an Adjuvant During Dural Puncture Epidural · NA · recruiting
- NCT07322471 — Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04419038 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Menoufia University
- Last refreshed: 5 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04419038.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing